{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:16:47Z","timestamp":1778501807102,"version":"3.51.4"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ccm.2016.11.009","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T15:00:32Z","timestamp":1482073232000},"page":"155-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vaccines in the Prevention of Viral Pneumonia"],"prefix":"10.1016","volume":"38","author":[{"given":"Clementine S.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.M.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib1","first-page":"010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J\u00a0Glob Health"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rmed.2006.04.006","article-title":"Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients","volume":"101","author":"Joos","year":"2007","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/499955","article-title":"Viral pneumonia in older adults","volume":"42","author":"Falsey","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9963","key":"10.1016\/j.ccm.2016.11.009_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Naghavi","year":"2015","journal-title":"Lancet"},{"issue":"9875","key":"10.1016\/j.ccm.2016.11.009_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(12)61901-1","article-title":"Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis","volume":"381","author":"Nair","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib7","doi-asserted-by":"crossref","first-page":"e0147982","DOI":"10.1371\/journal.pone.0147982","article-title":"Respiratory viruses associated hospitalization among children aged <5 years in Bangladesh: 2010-2014","volume":"11","author":"Homaira","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib8","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2052-8426-1-2","article-title":"Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?","volume":"1","author":"Jalilian","year":"2013","journal-title":"Mol Cell Ther"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/fmb.15.110","article-title":"DNA-based influenza vaccines as immunoprophylactic agents toward universality","volume":"11","author":"Zhang","year":"2015","journal-title":"Future Microbiol"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1566523215666150929111048","article-title":"Influenza plasmid DNA vaccines: progress and prospects","volume":"15","author":"Bicho","year":"2015","journal-title":"Curr Gene Ther"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ccm.2016.11.009_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2016.11.009_bib14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(12)70292-X","article-title":"Human microbial challenge: the ultimate animal model","volume":"12","author":"Pollard","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2016.11.009_bib15","unstructured":"WHO. WHO seasonal influenza. Bulletin of the World Health Organization. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/. Accessed May 24, 2016."},{"key":"10.1016\/j.ccm.2016.11.009_bib16","unstructured":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. CDC Pink Book. Available at: http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/flu.html. Accessed May 24, 2016."},{"key":"10.1016\/j.ccm.2016.11.009_bib17","unstructured":"WHO. Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. Available at: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/201602_recommendation.pdf?ua=1. Accessed May 24, 2016."},{"issue":"RR-8","key":"10.1016\/j.ccm.2016.11.009_bib18","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib20","article-title":"Vaccines for preventing influenza in healthy adults (Review)","author":"Demicheli","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.00133510","article-title":"Influenza vaccination is associated with reduced severity of community-acquired pneumonia","volume":"38","author":"Tessmer","year":"2011","journal-title":"Eur Respir J"},{"issue":"8975","key":"10.1016\/j.ccm.2016.11.009_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(95)91434-X","article-title":"Reduction in mortality associated with influenza vaccine during 1989-90 epidemic","volume":"346","author":"Ahmed","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/14760584.3.6.643","article-title":"Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine","volume":"3","author":"Belshe","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"RR-07","key":"10.1016\/j.ccm.2016.11.009_bib24","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2013United States, 2013-2014","volume":"62","author":"Centre for Disease Control and Prevention","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ccm.2016.11.009_bib25","unstructured":"WHO. Vaccines against influenza WHO position paper - November 2012. Weekly epidemiological record. Available at: http:\/\/www.who.int\/wer\/2012\/wer8747.pdf?ua=1. Accessed May 24, 2016."},{"key":"10.1016\/j.ccm.2016.11.009_bib26","unstructured":"The Department of Health, Public Health England. The Department Health\/Pubic Health England: The National Flu Immunisation Programme 2015\/16. Available at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/526144\/Annual_flu_letter_24_03_15superseded.pdf. Accessed May 27, 2016."},{"key":"10.1016\/j.ccm.2016.11.009_bib27","doi-asserted-by":"crossref","first-page":"d3214","DOI":"10.1136\/bmj.d3214","article-title":"Perinatal outcomes after maternal 2009\/H1N1 infection: national cohort study","volume":"342","author":"Pierce","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/14760584.2016.1175304","article-title":"Maternal vaccination for the prevention of influenza: current status and hopes for the future","volume":"15","author":"Phadke","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"15","key":"10.1016\/j.ccm.2016.11.009_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9929","key":"10.1016\/j.ccm.2016.11.009_bib30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(14)60583-3","article-title":"Influenza vaccine in pregnancy: policy and research strategies","volume":"383","author":"Steinhoff","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ccm.2016.11.009_bib31","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMc0912599","article-title":"Influenza immunization in pregnancy\u2013antibody responses in mothers and infants","volume":"362","author":"Steinhoff","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2016.11.009_bib32","unstructured":"Centers for Disease Control and Prevention. Vaccination coverage among persons with asthma \u2013 United States, 2010-2011 influenza season. Morbidity and mortality weekly report. Available at: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6248a1.htm. Accessed May 24, 2016."},{"issue":"7","key":"10.1016\/j.ccm.2016.11.009_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ccm.2016.11.009_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008965.pub3","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2016.11.009_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ccm.2016.11.009_bib37","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccm.2016.11.009_bib38","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cit379","article-title":"Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness","volume":"57","author":"Sundaram","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.165.3.265","article-title":"Impact of influenza vaccination on seasonal mortality in the US elderly population","volume":"165","author":"Simonsen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2016.11.009_bib42","first-page":"1","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst"},{"issue":"12","key":"10.1016\/j.ccm.2016.11.009_bib43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1473-3099(14)70960-0","article-title":"Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies","volume":"14","author":"Darvishian","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2016.11.009_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CIA.S25215","article-title":"Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence","volume":"7","author":"Lang","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"50","key":"10.1016\/j.ccm.2016.11.009_bib45","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza","volume":"31","author":"Beyer","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ccm.2016.11.009_bib46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2016.11.009_bib47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1586\/14760584.2013.811193","article-title":"Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults","volume":"12","author":"McElhaney","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ccm.2016.11.009_bib49","unstructured":"O'Flanagan D, Cotter S, Mereckiene J. Seasonal influenza vaccination in EU \/ EEA, influenza season 2011-12, Vaccine European New Integrated Collaboration (VENICE ) II Consortium September 2012- February 2013. Available at: http:\/\/venice.cineca.org\/VENICE_Seasonal_Influenza_2011-12_1.0v.pdf. Accessed June 1, 2016."},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000364.pub3","article-title":"Vaccines for preventing influenza in people with asthma","author":"Cates","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3132\/pcrj.2007.00056","article-title":"Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma","volume":"16","author":"Lyn-Cook","year":"2007","journal-title":"Prim Care Respir J"},{"issue":"21","key":"10.1016\/j.ccm.2016.11.009_bib53","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"Influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/thx.2009.133728","article-title":"Impact of the 2009 influenza pandemic","volume":"65","author":"Dunning","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2016.11.009_bib55","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/hv.8.1.18214","article-title":"Correlates of vaccine protection from influenza and its complications","volume":"8","author":"McCullers","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/vaccines2040707","article-title":"Overview of serological techniques for influenza vaccine evaluation: past, present and future","volume":"2","author":"Trombetta","year":"2014","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barria","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib60","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib62","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T\u00a0cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"9492","key":"10.1016\/j.ccm.2016.11.009_bib63","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a\u00a0cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"issue":"52","key":"10.1016\/j.ccm.2016.11.009_bib65","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1016\/j.vaccine.2012.10.007","article-title":"Adjuvants in influenza vaccines","volume":"30","author":"Tetsutani","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib66","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J\u00a0Virol"},{"issue":"9","key":"10.1016\/j.ccm.2016.11.009_bib67","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib68","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ccm.2016.11.009_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1743-422X-7-351","article-title":"Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development","volume":"7","author":"Stanekov\u00e1","year":"2010","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib70","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/649428","article-title":"A\u00a0novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1","volume":"201","author":"Wacheck","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2016.11.009_bib71","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","article-title":"Progress on adenovirus-vectored universal influenza vaccines","volume":"11","author":"Xiang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ccm.2016.11.009_bib72","first-page":"84","article-title":"Respiratory syncytial virus","volume":"72","author":"Jha","year":"2016","journal-title":"Eur Respir Soc Monogr"},{"issue":"9725","key":"10.1016\/j.ccm.2016.11.009_bib73","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1413456","article-title":"Viral bronchiolitis in children","volume":"374","author":"Meissner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"22","key":"10.1016\/j.ccm.2016.11.009_bib77","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1128\/JVI.76.22.11561-11569.2002","article-title":"Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV\u00a0infection","volume":"76","author":"De Swart","year":"2002","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial","volume":"23","author":"Acosta","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.ccm.2016.11.009_bib79","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.1217580110","article-title":"Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells","volume":"110","author":"Loebbermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.2014.878653","article-title":"Current concepts and progress in RSV vaccine development","volume":"13","author":"Guvenel","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib81","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/jvi.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J\u00a0Virol"},{"issue":"6136","key":"10.1016\/j.ccm.2016.11.009_bib82","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.ccm.2016.11.009_bib83","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1128\/JVI.01604-08","article-title":"The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes","volume":"82","author":"Bukreyev","year":"2008","journal-title":"J\u00a0Virol"},{"issue":"24","key":"10.1016\/j.ccm.2016.11.009_bib84","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1128\/JVI.01741-13","article-title":"Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses","volume":"87","author":"Chirkova","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib85","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/vaccines3040829","article-title":"Layer-by-layer nanoparticle vaccines carrying the G Protein CX3C motif protect against RSV infection and disease","volume":"3","author":"Jorquera","year":"2015","journal-title":"Vaccines"},{"issue":"6158","key":"10.1016\/j.ccm.2016.11.009_bib86","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccm.2016.11.009_bib87","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1038\/ncomms10224","article-title":"RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection","volume":"6","author":"Jozwik","year":"2015","journal-title":"Nat Commun"},{"issue":"3 Pt 1","key":"10.1016\/j.ccm.2016.11.009_bib88","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"19","key":"10.1016\/j.ccm.2016.11.009_bib89","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"Committee on Infectious Diseases and Bronchiolitis Guidelines","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2016.11.009_bib91","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ccm.2016.11.009_bib92","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S1473-3099(15)00247-9","article-title":"Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial","volume":"15","author":"O\u2019Brien","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib93","doi-asserted-by":"crossref","first-page":"e77104","DOI":"10.1371\/journal.pone.0077104","article-title":"Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age","volume":"8","author":"Malkin","year":"2013","journal-title":"PLoS One"},{"issue":"47","key":"10.1016\/j.ccm.2016.11.009_bib94","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1016\/j.vaccine.2015.06.119","article-title":"The changing landscape of respiratory syncytial virus","volume":"33","author":"Polack","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2016.11.009_bib95","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S1473-3099(16)00119-5","article-title":"Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?","volume":"16","author":"Saso","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2016.11.009_bib96","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.11.009_bib97","unstructured":"PATH. Vaccine development \u2013 Vaccine Development Global Program. Available at: http:\/\/sites.path.org\/vaccinedevelopment\/respiratory-syncytial-virus-rsv\/vaccine-development\/. Accessed May 19, 2016."},{"key":"10.1016\/j.ccm.2016.11.009_bib98","unstructured":"Munoz FM. Parainfluenza viruses in children. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/parainfluenza-viruses-in-children.Accessed May 20, 2016."},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib99","doi-asserted-by":"crossref","first-page":"e0148258","DOI":"10.1371\/journal.pone.0148258","article-title":"Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders","volume":"11","author":"Lehners","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib100","doi-asserted-by":"crossref","first-page":"ofv139","DOI":"10.1093\/ofid\/ofv139","article-title":"Parainfluenza virus infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected children and adults hospitalized for severe acute respiratory illness in South Africa, 2009\u20132014","volume":"2","author":"Cohen","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ccm.2016.11.009_bib101","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2105\/AJPH.52.6.907","article-title":"Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses","volume":"52","author":"Parrott","year":"1962","journal-title":"Am J Public Health Nations Health"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib102","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/infdis\/150.6.851","article-title":"Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children","volume":"150","author":"Glezen","year":"1984","journal-title":"J\u00a0Infect Dis"},{"issue":"04","key":"10.1016\/j.ccm.2016.11.009_bib103","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0031-1283289","article-title":"Progress in respiratory virus vaccine development","volume":"32","author":"Schmidt","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2016.11.009_bib104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.inf.0000066244.31769.83","article-title":"A\u00a0live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants","volume":"22","author":"Karron","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.ccm.2016.11.009_bib105","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A\u00a0live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"1995","journal-title":"J\u00a0Infect Dis"},{"issue":"13","key":"10.1016\/j.ccm.2016.11.009_bib106","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.vaccine.2005.12.002","article-title":"Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers","volume":"24","author":"Madhi","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib107","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/381184","article-title":"Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old","volume":"189","author":"Belshe","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib108","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/ers.11.32","article-title":"Progress in the development of human parainfluenza virus vaccines","volume":"5","author":"Schmidt","year":"2011","journal-title":"Expert Rev Respir Med"},{"issue":"48","key":"10.1016\/j.ccm.2016.11.009_bib109","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1016\/j.vaccine.2013.09.046","article-title":"Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children","volume":"31","author":"Englund","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/infdis\/157.4.655","article-title":"Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge","volume":"157","author":"van Wyke Coelingh","year":"1988","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2016.11.009_bib111","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428092","article-title":"A\u00a0bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy","volume":"191","author":"Greenberg","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"26","key":"10.1016\/j.ccm.2016.11.009_bib112","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.vaccine.2011.12.022","article-title":"Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children","volume":"30","author":"Karron","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jpids\/piu104","article-title":"Evaluation of a live-attenuated human parainfluenza type 1 vaccine in adults and children","volume":"4","author":"Karron","year":"2015","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"issue":"10","key":"10.1016\/j.ccm.2016.11.009_bib114","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1128\/JVI.75.10.4594-4603.2001","article-title":"Recombinant bovine\/human parainfluenza virus type 3 (B\/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3","volume":"75","author":"Schmidt","year":"2001","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.ccm.2016.11.009_bib115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/INF.0b013e31823386f1","article-title":"Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children","volume":"31","author":"Bernstein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib116","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib117","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3201\/eid1803.111238","article-title":"Adenovirus-associated deaths in US military during postvaccination period, 1999\u20132010","volume":"18","author":"Potter","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2016.11.009_bib118","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarr\u00eda","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.ccm.2016.11.009_bib119","first-page":"29","article-title":"Appraisal of occurrence of adenovirus-caused respiratory illness in military populations","volume":"66","author":"Hilleman","year":"1957","journal-title":"Am J Hyg"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"28","key":"10.1016\/j.ccm.2016.11.009_bib121","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2013.04.035","article-title":"A\u00a0phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits","volume":"31","author":"Kuschner","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ccm.2016.11.009_bib122","first-page":"2","article-title":"Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012","volume":"19","author":"Hoke","year":"2012","journal-title":"MSMR"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116301307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116301307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:55:28Z","timestamp":1759452928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523116301307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0272523116301307"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2016.11.009","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines in the Prevention of Viral Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}